Corporate Members
The MBI encourages involvement from those in private industry. The Institute offers incentives to pharmaceutical and bioengineering companies interested in becoming a Corporate Member.
Membership benefits include:
- regular visits by MBI Directors to identify problems and topics of interest, where mathematical sciences could be helpful;
- follow-up to these problems by Institute Researchers; and
- invitation to present industrial challenges and problems to MBI audiences and to participate in MBI programs and workshops.
Current Corporate Members:
- Pfizer
- GlaxoSmithKline
